Federal drug regulators have ordered that strong warnings be placed on the labels of attention-deficit/hyperactivity disorder (ADHD) drugs like Concerta, Strattera, and Ritalin. The labels caution against the drugs' use in people with heart problems because there have been reports of children with heart defects dying while taking the medicines. The new labeling also warns that some children who take ADHD drugs may experience hallucinations.
Read moreAh yes, the never ending debate of medicating, over-medicating, under-medicating and misdiagnosing ADD/ADHD. For me, I'd have to say it was... Read more »
Source: First DataBank
Generic Name: METHYLPHENIDATE SUSTAINED-ACTION, OSMOTIC - ORAL Pronounced: (meth-ill-FEN-eh-date) Warning Misuse or abuse of methylphenidate may... Read more »
Concerta's maker says that the drug is manufactured to make it harder to abuse. Concerta is made with "Oros technology," which makes the pills harder... Read more »
This is a study to compare the safety and effectiveness of five different dose levels of Concerta extended-release tablets compared to a placebo in... Read more »
A reader whose son has been taking Concerta since age 3 asks Dr. Melvin Oatis if she should be concerned about long-term use of the medicine in... Read more »
A European study showed that Concerta significantly eased symptoms of attention-deficit/hyperactivity disorder in adults. The trial was carried out... Read more »